Heights Capital Management’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
Other funds holding PRQR
6CM
KCM
LCM
Heights Capital Management's PRQR Position: Q3 2026 in Review
Heights Capital Management reduced its ProQR Therapeutics (PRQR) stake by 55% in Q3 2026, selling an estimated $2.88M and leaving 1,239,212 shares worth $2.06M. The position accounts for 0.42% of the portfolio, ranked #68.
Heights Capital Management first reported a position in PRQR in Q2 2026 and has held it in 2 quarters since. The position peaked at $5.14M in Q2 2026. 73 funds tracked by Wall St. Rank hold PRQR as of Q3 2026.
- Heights Capital Management held 1,239,212 shares of ProQR Therapeutics worth $2.06M as of Q3 2026.
- Heights Capital Management sold 1,523,218 ProQR Therapeutics shares in Q3 2026, an estimated $2.88M.
- ProQR Therapeutics made up 0.42% of Heights Capital Management's portfolio in Q3 2026, its #68 holding.
- Heights Capital Management first reported a position in ProQR Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Heights Capital Management's ProQR Therapeutics position peaked at $5.14M in Q2 2026.
- 73 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2026.
Based on Heights Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.